Dwight Klemm
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 18 | 2025 | 221 | 3.780 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 19 | 2014 | 145 | 2.820 |
Why?
| | Adipose Tissue | 10 | 2022 | 657 | 1.580 |
Why?
| | Leptin | 4 | 2025 | 244 | 1.560 |
Why?
| | Muscle, Smooth, Vascular | 10 | 2016 | 451 | 1.420 |
Why?
| | Pulmonary Artery | 11 | 2013 | 1136 | 1.280 |
Why?
| | Bone Marrow Cells | 5 | 2021 | 321 | 1.160 |
Why?
| | Hematopoietic Stem Cells | 5 | 2025 | 422 | 1.100 |
Why?
| | Myocytes, Smooth Muscle | 5 | 2016 | 265 | 0.960 |
Why?
| | Cell Differentiation | 16 | 2021 | 2060 | 0.800 |
Why?
| | Adipocytes, White | 2 | 2015 | 19 | 0.790 |
Why?
| | Thiazolidinediones | 4 | 2010 | 137 | 0.790 |
Why?
| | Stem Cells | 5 | 2017 | 626 | 0.700 |
Why?
| | Cell Lineage | 6 | 2019 | 378 | 0.700 |
Why?
| | PPAR gamma | 6 | 2009 | 176 | 0.640 |
Why?
| | Hypoxia | 7 | 2013 | 1201 | 0.640 |
Why?
| | Insulin Resistance | 4 | 2025 | 1255 | 0.560 |
Why?
| | Platelet-Derived Growth Factor | 2 | 2010 | 90 | 0.550 |
Why?
| | Animals | 54 | 2025 | 38331 | 0.550 |
Why?
| | Insulin | 8 | 2022 | 2511 | 0.540 |
Why?
| | Integrin beta1 | 1 | 2017 | 33 | 0.510 |
Why?
| | Mice | 30 | 2025 | 18549 | 0.500 |
Why?
| | Hypertension, Pulmonary | 8 | 2014 | 1979 | 0.490 |
Why?
| | Promoter Regions, Genetic | 12 | 2015 | 1257 | 0.490 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 17 | 0.420 |
Why?
| | Wnt Proteins | 2 | 2020 | 136 | 0.420 |
Why?
| | Myeloid Cells | 2 | 2017 | 148 | 0.410 |
Why?
| | Ovariectomy | 2 | 2025 | 162 | 0.410 |
Why?
| | Adipogenesis | 2 | 2017 | 57 | 0.400 |
Why?
| | Rats, Inbred WKY | 5 | 2013 | 37 | 0.390 |
Why?
| | Rats | 18 | 2024 | 5632 | 0.390 |
Why?
| | rho-Associated Kinases | 1 | 2013 | 83 | 0.390 |
Why?
| | Cell Separation | 2 | 2014 | 312 | 0.390 |
Why?
| | Flow Cytometry | 3 | 2014 | 1193 | 0.390 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2007 | 32 | 0.360 |
Why?
| | CREB-Binding Protein | 3 | 2008 | 33 | 0.340 |
Why?
| | Cells, Cultured | 14 | 2017 | 4177 | 0.340 |
Why?
| | Intra-Abdominal Fat | 1 | 2011 | 101 | 0.320 |
Why?
| | Casein Kinase II | 1 | 2010 | 22 | 0.320 |
Why?
| | Transcription, Genetic | 10 | 2001 | 1506 | 0.320 |
Why?
| | Protein Kinases | 5 | 2004 | 315 | 0.310 |
Why?
| | Hydrogen Peroxide | 1 | 2011 | 340 | 0.300 |
Why?
| | Mesoderm | 1 | 2010 | 150 | 0.300 |
Why?
| | Cell Division | 5 | 2009 | 780 | 0.300 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2001 | 273 | 0.290 |
Why?
| | Adenovirus E1A Proteins | 2 | 2000 | 15 | 0.290 |
Why?
| | Cell Nucleus | 8 | 2010 | 619 | 0.290 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 6 | 1997 | 26 | 0.280 |
Why?
| | Cyclin D1 | 1 | 2008 | 68 | 0.280 |
Why?
| | Trans-Activators | 3 | 2001 | 399 | 0.280 |
Why?
| | Protein Kinase Inhibitors | 3 | 2013 | 1003 | 0.270 |
Why?
| | Activating Transcription Factor 1 | 3 | 2006 | 9 | 0.270 |
Why?
| | Nuclear Proteins | 5 | 2001 | 754 | 0.270 |
Why?
| | Wnt Signaling Pathway | 3 | 2020 | 212 | 0.250 |
Why?
| | Energy Metabolism | 4 | 2024 | 946 | 0.250 |
Why?
| | Cell Proliferation | 6 | 2013 | 2543 | 0.250 |
Why?
| | Gene Expression Regulation | 7 | 2010 | 2633 | 0.250 |
Why?
| | Blotting, Western | 6 | 2011 | 1207 | 0.240 |
Why?
| | Cyclic AMP | 4 | 2000 | 209 | 0.240 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2006 | 87 | 0.230 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2006 | 163 | 0.220 |
Why?
| | Cell Movement | 3 | 2011 | 977 | 0.220 |
Why?
| | Signal Transduction | 5 | 2013 | 5277 | 0.220 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 248 | 0.220 |
Why?
| | Rats, Wistar | 2 | 2024 | 460 | 0.220 |
Why?
| | Adiponectin | 2 | 2022 | 247 | 0.210 |
Why?
| | Phosphorylation | 10 | 2010 | 1763 | 0.210 |
Why?
| | Neoplasm Proteins | 2 | 2014 | 450 | 0.210 |
Why?
| | 3T3-L1 Cells | 4 | 2008 | 36 | 0.210 |
Why?
| | Mice, Inbred C57BL | 10 | 2025 | 6067 | 0.210 |
Why?
| | Cell Line | 12 | 2020 | 2911 | 0.210 |
Why?
| | Mitochondria, Muscle | 2 | 2016 | 121 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2013 | 442 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 83 | 0.200 |
Why?
| | Adaptation, Physiological | 3 | 2016 | 573 | 0.200 |
Why?
| | Blood Vessels | 2 | 2007 | 173 | 0.190 |
Why?
| | Adipose Tissue, White | 2 | 2024 | 43 | 0.190 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 250 | 0.190 |
Why?
| | Pulmonary Fibrosis | 4 | 2017 | 404 | 0.180 |
Why?
| | Transcription Factors | 8 | 2003 | 1741 | 0.180 |
Why?
| | Lipid Metabolism | 1 | 2006 | 526 | 0.180 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 2 | 2004 | 630 | 0.180 |
Why?
| | Ecdysterone | 1 | 2001 | 2 | 0.180 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2012 | 384 | 0.180 |
Why?
| | Lung | 6 | 2020 | 4190 | 0.170 |
Why?
| | Neovascularization, Pathologic | 2 | 2020 | 290 | 0.170 |
Why?
| | Metabolic Diseases | 1 | 2021 | 114 | 0.160 |
Why?
| | Estradiol | 1 | 2024 | 539 | 0.160 |
Why?
| | Mice, Transgenic | 4 | 2017 | 2196 | 0.160 |
Why?
| | Receptors, Glucocorticoid | 2 | 2001 | 139 | 0.160 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2013 | 149 | 0.160 |
Why?
| | Phosphatidylglycerols | 3 | 1988 | 18 | 0.160 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2001 | 267 | 0.150 |
Why?
| | Airway Remodeling | 1 | 2020 | 71 | 0.150 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 233 | 0.150 |
Why?
| | Muscle Proteins | 1 | 2001 | 248 | 0.150 |
Why?
| | Pulmonary Circulation | 2 | 2013 | 431 | 0.150 |
Why?
| | Nitric Oxide Synthase Type III | 3 | 2015 | 207 | 0.150 |
Why?
| | Endothelium, Vascular | 2 | 2020 | 968 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2016 | 202 | 0.140 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 71 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-sis | 2 | 2010 | 39 | 0.140 |
Why?
| | RNA, Small Interfering | 3 | 2011 | 646 | 0.140 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 59 | 0.140 |
Why?
| | Pericytes | 2 | 2017 | 36 | 0.140 |
Why?
| | Leukemia, Experimental | 2 | 1988 | 28 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 1996 | 1498 | 0.140 |
Why?
| | Metabolome | 1 | 2021 | 388 | 0.140 |
Why?
| | Transfection | 8 | 2001 | 952 | 0.140 |
Why?
| | Tumor Cells, Cultured | 6 | 1998 | 944 | 0.130 |
Why?
| | Protein Stability | 2 | 2017 | 180 | 0.130 |
Why?
| | Apoptosis | 2 | 2006 | 2454 | 0.130 |
Why?
| | Fibrosis | 1 | 2019 | 548 | 0.130 |
Why?
| | Female | 13 | 2025 | 78213 | 0.130 |
Why?
| | Macrophages | 2 | 2017 | 1532 | 0.120 |
Why?
| | Phosphoprotein Phosphatases | 2 | 1994 | 65 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 4 | 2006 | 685 | 0.120 |
Why?
| | Fibrin | 1 | 2017 | 91 | 0.120 |
Why?
| | Extracellular Matrix | 2 | 2013 | 564 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2000 | 600 | 0.120 |
Why?
| | Cell Fusion | 1 | 2015 | 49 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 98 | 0.120 |
Why?
| | Estrogens | 1 | 2018 | 381 | 0.110 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1996 | 227 | 0.110 |
Why?
| | Humans | 31 | 2021 | 144848 | 0.110 |
Why?
| | Adamantane | 1 | 2015 | 17 | 0.110 |
Why?
| | Dipeptides | 1 | 2015 | 57 | 0.110 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1994 | 17 | 0.110 |
Why?
| | Interferons | 1 | 1996 | 193 | 0.110 |
Why?
| | Free Radical Scavengers | 2 | 2011 | 86 | 0.110 |
Why?
| | Exercise | 2 | 2018 | 2206 | 0.100 |
Why?
| | Mice, Knockout | 6 | 2016 | 3147 | 0.100 |
Why?
| | Vasodilator Agents | 2 | 2013 | 332 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1994 | 99 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2013 | 25 | 0.100 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2014 | 120 | 0.100 |
Why?
| | Male | 13 | 2020 | 72182 | 0.100 |
Why?
| | Bucladesine | 4 | 2000 | 20 | 0.100 |
Why?
| | Arterioles | 1 | 2013 | 56 | 0.100 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 84 | 0.100 |
Why?
| | Glucocorticoids | 1 | 1997 | 540 | 0.100 |
Why?
| | Models, Biological | 3 | 2021 | 1837 | 0.100 |
Why?
| | Cell Survival | 2 | 2006 | 1113 | 0.100 |
Why?
| | PPAR alpha | 2 | 2010 | 57 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.090 |
Why?
| | Bleomycin | 2 | 2011 | 260 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 1996 | 475 | 0.090 |
Why?
| | Enzyme Activation | 5 | 2010 | 783 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 412 | 0.090 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1089 | 0.090 |
Why?
| | Serine | 2 | 2006 | 138 | 0.090 |
Why?
| | Base Sequence | 7 | 2003 | 2188 | 0.090 |
Why?
| | Binding Sites | 2 | 2008 | 1314 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 2108 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 681 | 0.080 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 37 | 0.080 |
Why?
| | Cytosol | 2 | 2010 | 227 | 0.080 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 8 | 0.080 |
Why?
| | Diet, High-Fat | 1 | 2012 | 262 | 0.080 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 33 | 0.080 |
Why?
| | Mutation | 4 | 2008 | 4132 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 2011 | 247 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 832 | 0.080 |
Why?
| | Liver | 6 | 2024 | 1853 | 0.080 |
Why?
| | Osteoblasts | 1 | 2011 | 145 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 723 | 0.080 |
Why?
| | Molecular Sequence Data | 7 | 2000 | 2914 | 0.080 |
Why?
| | Leukocyte Common Antigens | 2 | 2007 | 87 | 0.080 |
Why?
| | Hyperoxia | 2 | 2009 | 100 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 124 | 0.080 |
Why?
| | Extracellular Space | 1 | 2010 | 132 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2007 | 1057 | 0.080 |
Why?
| | Genes | 1 | 1990 | 226 | 0.080 |
Why?
| | Lipoproteins, LDL | 1 | 2010 | 114 | 0.080 |
Why?
| | Kinetics | 4 | 2000 | 1627 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2006 | 750 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2010 | 649 | 0.070 |
Why?
| | Mice, Nude | 2 | 2011 | 692 | 0.070 |
Why?
| | DNA-Binding Proteins | 5 | 2003 | 1495 | 0.070 |
Why?
| | Osteogenesis | 1 | 2011 | 207 | 0.070 |
Why?
| | 3T3 Cells | 2 | 2000 | 159 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 210 | 0.070 |
Why?
| | Neprilysin | 1 | 2009 | 46 | 0.070 |
Why?
| | Cell Culture Techniques | 1 | 2011 | 380 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 423 | 0.070 |
Why?
| | Dietary Fats | 2 | 2010 | 316 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 766 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2010 | 351 | 0.070 |
Why?
| | Respiratory System | 1 | 2009 | 160 | 0.070 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 197 | 0.070 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2011 | 276 | 0.070 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 331 | 0.070 |
Why?
| | Mitochondria | 1 | 2014 | 988 | 0.060 |
Why?
| | Protein Binding | 2 | 2008 | 2276 | 0.060 |
Why?
| | Phosphatidylinositols | 1 | 1987 | 59 | 0.060 |
Why?
| | Perilipin-1 | 1 | 2006 | 17 | 0.060 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2006 | 18 | 0.060 |
Why?
| | Up-Regulation | 1 | 2010 | 864 | 0.060 |
Why?
| | Collagenases | 1 | 2006 | 22 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 300 | 0.060 |
Why?
| | CD11 Antigens | 1 | 2006 | 31 | 0.060 |
Why?
| | Disease Models, Animal | 5 | 2015 | 4605 | 0.060 |
Why?
| | Elastin | 1 | 2006 | 84 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2006 | 43 | 0.060 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2006 | 50 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2006 | 72 | 0.060 |
Why?
| | Spleen | 1 | 1988 | 518 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 561 | 0.060 |
Why?
| | Obesity | 2 | 2012 | 3107 | 0.060 |
Why?
| | Ubiquitin | 1 | 2006 | 86 | 0.060 |
Why?
| | Adenosine Triphosphate | 2 | 2004 | 499 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2010 | 404 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2014 | 874 | 0.060 |
Why?
| | Age Factors | 2 | 2010 | 3310 | 0.060 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 97 | 0.060 |
Why?
| | Interleukin-4 | 2 | 1997 | 213 | 0.060 |
Why?
| | Myofibroblasts | 2 | 2019 | 144 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2000 | 157 | 0.060 |
Why?
| | Acetylcysteine | 1 | 2006 | 141 | 0.060 |
Why?
| | HIV Protease Inhibitors | 1 | 2006 | 69 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 2006 | 294 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2006 | 192 | 0.060 |
Why?
| | Cattle | 3 | 2004 | 1006 | 0.060 |
Why?
| | Green Fluorescent Proteins | 1 | 2006 | 406 | 0.060 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 35 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2224 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 992 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2006 | 348 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2090 | 0.050 |
Why?
| | Fatty Liver | 1 | 2007 | 255 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 4 | 2010 | 2538 | 0.050 |
Why?
| | Collagen | 1 | 2006 | 467 | 0.050 |
Why?
| | Aorta | 2 | 2010 | 432 | 0.050 |
Why?
| | Protein Phosphatase 2 | 2 | 1994 | 41 | 0.050 |
Why?
| | Genes, Dominant | 1 | 2003 | 100 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2011 | 2045 | 0.050 |
Why?
| | DNA Methylation | 1 | 2008 | 681 | 0.050 |
Why?
| | Graft Occlusion, Vascular | 1 | 2003 | 42 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1829 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2006 | 1033 | 0.050 |
Why?
| | Lung Diseases | 1 | 2009 | 796 | 0.050 |
Why?
| | Ovary | 1 | 2024 | 227 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4279 | 0.050 |
Why?
| | Adiposity | 1 | 2007 | 542 | 0.040 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2014 | 197 | 0.040 |
Why?
| | Genes, Reporter | 2 | 2000 | 276 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2000 | 362 | 0.040 |
Why?
| | Protein Prenylation | 1 | 2001 | 19 | 0.040 |
Why?
| | Fatty Acid Synthases | 1 | 2001 | 21 | 0.040 |
Why?
| | Glucose Transporter Type 4 | 1 | 2001 | 38 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2003 | 324 | 0.040 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2001 | 56 | 0.040 |
Why?
| | Hypertension | 1 | 2010 | 1241 | 0.040 |
Why?
| | Fibroblasts | 2 | 2009 | 1042 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2001 | 376 | 0.040 |
Why?
| | Polymerase Chain Reaction | 3 | 2011 | 1058 | 0.040 |
Why?
| | Myelin P2 Protein | 1 | 2000 | 2 | 0.040 |
Why?
| | Fatty Acid-Binding Protein 7 | 1 | 2000 | 4 | 0.040 |
Why?
| | Hypoglycemic Agents | 2 | 2007 | 1398 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2599 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 75 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1752 | 0.040 |
Why?
| | Antigens, Differentiation | 1 | 2000 | 78 | 0.040 |
Why?
| | Body Composition | 1 | 2024 | 716 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2016 | 1099 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 674 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 993 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 36 | 0.040 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2000 | 79 | 0.040 |
Why?
| | Vascular System Injuries | 1 | 2020 | 80 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 133 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2001 | 316 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 2 | 2001 | 580 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 130 | 0.040 |
Why?
| | Dexamethasone | 1 | 2001 | 373 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 218 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 254 | 0.030 |
Why?
| | Recombinant Proteins | 3 | 2003 | 1358 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 501 | 0.030 |
Why?
| | Molecular Weight | 2 | 1988 | 325 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1734 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1060 | 0.030 |
Why?
| | Pulmonary Emphysema | 1 | 2020 | 310 | 0.030 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 52 | 0.030 |
Why?
| | Drug Resistance | 1 | 1997 | 154 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2001 | 1225 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 1997 | 81 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2016 | 32 | 0.030 |
Why?
| | Gonads | 1 | 2016 | 23 | 0.030 |
Why?
| | Blast Crisis | 1 | 2016 | 35 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2181 | 0.030 |
Why?
| | Cytoprotection | 1 | 2016 | 55 | 0.030 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1996 | 13 | 0.030 |
Why?
| | Liver Neoplasms, Experimental | 1 | 1996 | 29 | 0.030 |
Why?
| | Lipolysis | 1 | 2016 | 46 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1997 | 447 | 0.030 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 1995 | 26 | 0.030 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 1995 | 30 | 0.030 |
Why?
| | Vasoconstriction | 1 | 2017 | 218 | 0.030 |
Why?
| | Animals, Newborn | 2 | 2009 | 904 | 0.030 |
Why?
| | Hypersensitivity, Immediate | 1 | 1995 | 41 | 0.030 |
Why?
| | Menopause | 1 | 2018 | 316 | 0.030 |
Why?
| | Retinoblastoma Protein | 1 | 1996 | 108 | 0.030 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 128 | 0.030 |
Why?
| | Superoxides | 1 | 2016 | 207 | 0.030 |
Why?
| | Organelle Biogenesis | 1 | 2015 | 15 | 0.030 |
Why?
| | Point Mutation | 1 | 1996 | 245 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 321 | 0.030 |
Why?
| | Neutrophils | 1 | 2001 | 1146 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1996 | 569 | 0.030 |
Why?
| | Exons | 1 | 1996 | 358 | 0.030 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 47 | 0.030 |
Why?
| | Protein Phosphatase 1 | 1 | 1994 | 32 | 0.030 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 1994 | 57 | 0.030 |
Why?
| | Gene Deletion | 1 | 1996 | 388 | 0.030 |
Why?
| | Asthma | 2 | 1997 | 1917 | 0.030 |
Why?
| | Oligonucleotide Probes | 2 | 1990 | 50 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2015 | 146 | 0.020 |
Why?
| | Okadaic Acid | 1 | 1993 | 15 | 0.020 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 1993 | 8 | 0.020 |
Why?
| | Ethers, Cyclic | 1 | 1993 | 11 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2014 | 180 | 0.020 |
Why?
| | Fatty Acids | 1 | 2016 | 451 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 139 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 1995 | 2149 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 255 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 1993 | 224 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1993 | 543 | 0.020 |
Why?
| | Antioxidants | 2 | 2009 | 581 | 0.020 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 1991 | 9 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2014 | 326 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 410 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 38 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2011 | 113 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2016 | 907 | 0.020 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 900 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2010 | 32 | 0.020 |
Why?
| | Rats, Inbred SHR | 1 | 2010 | 38 | 0.020 |
Why?
| | Templates, Genetic | 1 | 1990 | 63 | 0.020 |
Why?
| | Receptors, LDL | 1 | 2010 | 53 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1990 | 97 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 154 | 0.020 |
Why?
| | Immunity, Innate | 1 | 1996 | 856 | 0.020 |
Why?
| | Tyrosine | 1 | 2010 | 227 | 0.020 |
Why?
| | Bronchoconstriction | 1 | 2009 | 29 | 0.020 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1993 | 373 | 0.020 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2016 | 683 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 178 | 0.020 |
Why?
| | Interleukin-3 | 1 | 1988 | 23 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 272 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1988 | 153 | 0.020 |
Why?
| | Capillary Permeability | 1 | 2009 | 136 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2009 | 151 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 223 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 517 | 0.020 |
Why?
| | Lung Injury | 1 | 2011 | 237 | 0.020 |
Why?
| | Species Specificity | 2 | 2001 | 576 | 0.020 |
Why?
| | Infant, Newborn, Diseases | 1 | 2009 | 114 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2003 | 379 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 7107 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 641 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 481 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 1987 | 75 | 0.020 |
Why?
| | Protein Kinase C | 1 | 1988 | 253 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 85 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 21 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2015 | 11581 | 0.020 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 55 | 0.020 |
Why?
| | Manganese | 1 | 1987 | 56 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 382 | 0.020 |
Why?
| | Microcirculation | 1 | 2007 | 138 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 66 | 0.020 |
Why?
| | Magnesium | 1 | 1987 | 154 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2010 | 456 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1987 | 328 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2009 | 6406 | 0.020 |
Why?
| | Liver Neoplasms | 1 | 1993 | 782 | 0.020 |
Why?
| | Substrate Specificity | 1 | 1987 | 385 | 0.020 |
Why?
| | Placenta | 1 | 1993 | 780 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 907 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 517 | 0.010 |
Why?
| | Inflammation | 1 | 2016 | 2911 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2100 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1841 | 0.010 |
Why?
| | DNA | 3 | 1997 | 1430 | 0.010 |
Why?
| | Hemodynamics | 1 | 2009 | 1117 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14028 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 278 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 332 | 0.010 |
Why?
| | Histones | 1 | 1988 | 658 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1833 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3199 | 0.010 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2007 | 414 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2001 | 46 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 453 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2001 | 2860 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3580 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2411 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 7197 | 0.010 |
Why?
| | Aged | 1 | 2020 | 25822 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2001 | 273 | 0.010 |
Why?
| | Cell Death | 1 | 2001 | 388 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1980 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2001 | 1272 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 35939 | 0.010 |
Why?
| | Adult | 2 | 2020 | 40438 | 0.010 |
Why?
| | Chickens | 1 | 1997 | 192 | 0.010 |
Why?
| | Glucose | 1 | 2001 | 1048 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1517 | 0.010 |
Why?
| | Plasmids | 1 | 1997 | 379 | 0.010 |
Why?
| | Lymphokines | 1 | 1995 | 130 | 0.010 |
Why?
| | Luciferases | 1 | 1995 | 153 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1995 | 189 | 0.010 |
Why?
| | Burkitt Lymphoma | 1 | 1995 | 63 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1994 | 64 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 162 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2001 | 1379 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 145 | 0.010 |
Why?
| | Interleukins | 1 | 1995 | 253 | 0.010 |
Why?
| | Bezoars | 1 | 1973 | 5 | 0.010 |
Why?
| | Stomach | 1 | 1973 | 109 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1991 | 36 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1991 | 24 | 0.010 |
Why?
| | Autoradiography | 1 | 1991 | 64 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1990 | 81 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1990 | 38 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 1991 | 122 | 0.000 |
Why?
| | Introns | 1 | 1991 | 252 | 0.000 |
Why?
| | HeLa Cells | 1 | 1991 | 654 | 0.000 |
Why?
| | Escherichia coli | 1 | 1990 | 854 | 0.000 |
Why?
| | Radiography | 1 | 1973 | 839 | 0.000 |
Why?
|
|
Klemm's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|